KẾT QUẢ SỚM ĐIỀU TRỊ UNG THƯ BIỂU MÔ TẾ BÀO GAN BẰNG ĐỐT NHIỆT SÓNG CAO TẦN

Abstract

Aims: To evaluate the results of early treatment of hepatocellular carcinoma by Radiofrequency ablation. Material and Methods: Includes 85 hepatocellular cancer patients who have been treated with RFA. Patients' clinical symptoms were recorded before and after treatment, as well as paraclinical examinations, the effectiveness of the RFA method, and RFA complications and complications. Results: Child-Pugh A and Child-Pugh B respectively account for 76.5% and 23.5 percent of the total. Before therapy, the average AFP concentration was 705.2 ± 1347.46 (ng/ml). Patients with one tumor accounted for 67.6% of the total, patients with two tumors accounted for 25%, and patients with three tumors accounted for 7.4% of the total. RFA took an average of 16.9 ± 4.32 minutes in the study group, and group 1 tumors took an average of 17.0 ± 4.39 minutes to burn. The time taken by the group with two tumors was 15.7 ± 3.69 minutes, and the time taken by the group with three tumors was 17.6 ± 5.16 minutes, although the difference was not statistically significant (p > 0.05). These problems are minor and can be treated with over-the-counter antipyretics and analgesics. For a total of 132 times, radiofrequency ablation was used on 85 participants in the study. There were three incidences of complications (3.5%) as a result of the procedure, however, no patient died. Median values of AFP concentration after treatment for 1 month, 3 months, the difference was statistically significant. Conclusion: Treatment of liver cancer by radiofrequency ablation is a method of treatment with good results and safety for patients with liver cancer.